Feil Family Brain & Mind Research Institute

Publications

Found 602 results
Author Title Type [ Year(Desc)]
Filters: First Letter Of Last Name is K  [Clear All Filters]
2017
Parikh NS, Merkler AE, Schneider Y, Navi BB, Kamel H.  2017.  Discharge Disposition After Stroke in Patients With Liver Disease.. Stroke. 48(2):476-478.
Starkov AA, Chinopoulos C, Starkova NN, Konrad C, Kiss G, Stepanova A, Popov VN.  2017.  Divalent cation chelators citrate and EDTA unmask an intrinsic uncoupling pathway in isolated mitochondria.. J Bioenerg Biomembr. 49(1):3-11.
Starkov AA, Chinopoulos C, Starkova NN, Konrad C, Kiss G, Stepanova A, Popov VN.  2017.  Divalent cation chelators citrate and EDTA unmask an intrinsic uncoupling pathway in isolated mitochondria.. J Bioenerg Biomembr. 49(1):3-11.
Martínez-Rivera A, Hao J, Tropea TF, Giordano TP, Kosovsky M, Rice RC, Lee A, Huganir RL, Striessnig J, Addy NA et al..  2017.  Enhancing VTA Cav1.3 L-type Ca2+ channel activity promotes cocaine and mood-related behaviors via overlapping AMPA receptor mechanisms in the nucleus accumbens.. Mol Psychiatry. 22(12):1735-1745.
Kamel H.  2017.  Evidence-Based Management of Patent Foramen Ovale in Patients With Ischemic Stroke.. JAMA Neurol.
Konrad C, Kawamata H, Bredvik KG, Arreguin AJ, Cajamarca SA, Hupf JC, Ravits JM, Miller TM, Maragakis NJ, Hales CM et al..  2017.  Fibroblast bioenergetics to classify amyotrophic lateral sclerosis patients.. Mol Neurodegener. 12(1):76.
Konrad C, Kawamata H, Bredvik KG, Arreguin AJ, Cajamarca SA, Hupf JC, Ravits JM, Miller TM, Maragakis NJ, Hales CM et al..  2017.  Fibroblast bioenergetics to classify amyotrophic lateral sclerosis patients.. Mol Neurodegener. 12(1):76.
Kabir ZD, Martinez-Rivera A, Rajadhyaksha AM.  2017.  From Gene to Behavior: L-Type Calcium Channel Mechanisms Underlying Neuropsychiatric Symptoms.. Neurotherapeutics. 14(3):588-613.
Lee D, Lee W-S, Lim S, Kim YKyung, Jung H-Y, Das S, Lee J, Luo W, Kim K-T, Chung S-K.  2017.  A guanidine-appended scyllo-inositol derivative AAD-66 enhances brain delivery and ameliorates Alzheimer's phenotypes.. Sci Rep. 7(1):14125.
Lee D, Lee W-S, Lim S, Kim YKyung, Jung H-Y, Das S, Lee J, Luo W, Kim K-T, Chung S-K.  2017.  A guanidine-appended scyllo-inositol derivative AAD-66 enhances brain delivery and ameliorates Alzheimer's phenotypes.. Sci Rep. 7(1):14125.
Schweitzer AD, Parikh NS, Askin G, Nemade A, Lyo J, Karimi S, Knobel A, Navi BB, Young RJ, Gupta A.  2017.  Imaging characteristics associated with clinical outcomes in posterior reversible encephalopathy syndrome.. Neuroradiology. 59(4):379-386.
Schweitzer AD, Parikh NS, Askin G, Nemade A, Lyo J, Karimi S, Knobel A, Navi BB, Young RJ, Gupta A.  2017.  Imaging characteristics associated with clinical outcomes in posterior reversible encephalopathy syndrome.. Neuroradiology. 59(4):379-386.
Kim E, Yang J, Park KWoo, Cho S.  2017.  Inhibition of VEGF Signaling Reduces Diabetes-Exacerbated Brain Swelling, but Not Infarct Size, in Large Cerebral Infarction in Mice.. Transl Stroke Res.
Reznik ME, Merkler AE, Mahta A, Murthy SB, Claassen J, Kamel H.  2017.  Long-term risk of seizures in adult survivors of sepsis.. Neurology. 89(14):1476-1482.
Glusman G, Rose PW, Prlić A, Dougherty J, Duarte JM, Hoffman AS, Barton GJ, Bendixen E, Bergquist T, Bock C et al..  2017.  Mapping genetic variations to three-dimensional protein structures to enhance variant interpretation: a proposed framework.. Genome Med. 9(1):113.
Kenny TC, Manfredi G, Germain D.  2017.  The Mitochondrial Unfolded Protein Response as a Non-Oncogene Addiction to Support Adaptation to Stress during Transformation in Cancer and Beyond.. Front Oncol. 7:159.
Fil D, DeLoach A, Yadav S, Alkam D, MacNicol M, Singh A, Compadre CM, Goellner JJ, O'Brien CA, Fahmi T et al..  2017.  Mutant Profilin1 transgenic mice recapitulate cardinal features of motor neuron disease.. Hum Mol Genet. 26(4):686-701.
Fil D, DeLoach A, Yadav S, Alkam D, MacNicol M, Singh A, Compadre CM, Goellner JJ, O'Brien CA, Fahmi T et al..  2017.  Mutant Profilin1 transgenic mice recapitulate cardinal features of motor neuron disease.. Hum Mol Genet. 26(4):686-701.
Fil D, DeLoach A, Yadav S, Alkam D, MacNicol M, Singh A, Compadre CM, Goellner JJ, O'Brien CA, Fahmi T et al..  2017.  Mutant Profilin1 transgenic mice recapitulate cardinal features of motor neuron disease.. Hum Mol Genet. 26(4):686-701.
Kawamata H, Peixoto P, Konrad C, Palomo G, Bredvik K, Gerges M, Valsecchi F, Petrucelli L, Ravits JM, Starkov A et al..  2017.  Mutant TDP-43 does not impair mitochondrial bioenergetics in vitro and in vivo.. Mol Neurodegener. 12(1):37.
Kawamata H, Peixoto P, Konrad C, Palomo G, Bredvik K, Gerges M, Valsecchi F, Petrucelli L, Ravits JM, Starkov A et al..  2017.  Mutant TDP-43 does not impair mitochondrial bioenergetics in vitro and in vivo.. Mol Neurodegener. 12(1):37.
Elsaid MFawzi, Chalhoub N, Ben-Omran T, Kumar P, Kamel H, Ibrahim K, Mohamoud Y, Al-Dous E, Al-Azwani I, Malek JA et al..  2017.  Mutation in noncoding RNA RNU12 causes early onset cerebellar ataxia.. Ann Neurol. 81(1):68-78.
Elsaid MFawzi, Chalhoub N, Ben-Omran T, Kumar P, Kamel H, Ibrahim K, Mohamoud Y, Al-Dous E, Al-Azwani I, Malek JA et al..  2017.  Mutation in noncoding RNA RNU12 causes early onset cerebellar ataxia.. Ann Neurol. 81(1):68-78.
Vu LP, Pickering BF, Cheng Y, Zaccara S, Nguyen D, Minuesa G, Chou T, Chow A, Saletore Y, MacKay M et al..  2017.  The N6-methyladenosine (m6A)-forming enzyme METTL3 controls myeloid differentiation of normal hematopoietic and leukemia cells.. Nat Med. 23(11):1369-1376.
Vu LP, Pickering BF, Cheng Y, Zaccara S, Nguyen D, Minuesa G, Chou T, Chow A, Saletore Y, MacKay M et al..  2017.  The N6-methyladenosine (m6A)-forming enzyme METTL3 controls myeloid differentiation of normal hematopoietic and leukemia cells.. Nat Med. 23(11):1369-1376.